New kidney disease registry aims to unlock secrets of FSGS and MCD
NCT ID NCT03949972
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This registry is gathering health information and biological samples from 500 people with focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD), two rare kidney conditions. Researchers will track participants over 10 years to understand how these diseases progress and affect quality of life. The goal is to build a resource that can help future studies find better ways to diagnose and treat these conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide the data and samples needed to develop better diagnostics and treatments for FSGS and MCD.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any therapy, and results may take years to impact patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLOMERULOSCLEROSIS, FOCAL SEGMENTAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité University Hospital
RECRUITINGBerlin, Germany
-
Kindernephrologie Dachau
RECRUITINGDachau, 85221, Germany
-
Kindernierenzentrum Bonn
RECRUITINGBonn, 53127, Germany
-
Klinikum St. Georg
RECRUITINGLeipzig, 04129, Germany
-
Klinikum Stuttgart
RECRUITINGStuttgart, 70174, Germany
-
Uniklinik RWTH Aachen
NOT_YET_RECRUITINGAachen, 52074, Germany
-
University Hospital Erlangen
NOT_YET_RECRUITINGErlangen, Germany
-
University Hospital Essen
RECRUITINGEssen, 45147, Germany
-
University Hospital Heidelberg
RECRUITINGHeidelberg, 69120, Germany
-
University Hospital Marburg
RECRUITINGMarburg, Germany
-
University Hospital Münster
RECRUITINGMünster, Germany
-
University Hospital of Cologne
RECRUITINGCologne, North Rhine-Westphalia, 50937, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney disease biobank aims to unlock new treatments
- Kidney disease mystery: scientists launch massive data hunt
- New pill aims to plug protein leak in kidney patients
- New biobank aims to unlock why kidney disease returns after transplant
- Ear-Zap therapy could spare kids from harsh kidney drugs
- Ear-Zap therapy could spare kids from steroid side effects